Core Viewpoint - Hims & Hers Health, Inc. is experiencing significant growth in earnings and revenue, with upcoming earnings expected to show substantial year-over-year increases, despite a recent decline in stock price [2][3]. Financial Performance - The stock of Hims & Hers Health, Inc. decreased by 2.95% to $56.00, underperforming the S&P 500's daily loss of 0.55% [1] - Over the past month, the stock has risen by 34.22%, contrasting with a 0.2% loss in the Medical sector and a 3.64% gain in the S&P 500 [1] - The company is projected to report an EPS of $0.09, reflecting a 50% growth compared to the same quarter last year, with anticipated revenue of $581.61 million, indicating a 44.84% increase year-over-year [2] - For the entire fiscal year, earnings are expected to be $0.6 per share and revenue is projected at $2.35 billion, representing increases of 122.22% and 58.91% respectively from the previous year [3] Analyst Sentiment - Recent revisions to analyst forecasts for Hims & Hers Health, Inc. are crucial, as positive estimate revisions indicate analyst optimism regarding the company's business and profitability [4] - The Zacks Rank system, which evaluates estimate changes, currently assigns Hims & Hers Health, Inc. a rank of 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [6] Valuation Metrics - Hims & Hers Health, Inc. has a Forward P/E ratio of 96.47, which is significantly higher than the industry average Forward P/E of 39.85 [7] - The company has a PEG ratio of 3.9, compared to the Medical Info Systems industry's average PEG ratio of 3.35, indicating a premium valuation relative to growth expectations [8] Industry Context - The Medical Info Systems industry, which includes Hims & Hers Health, Inc., holds a Zacks Industry Rank of 70, placing it in the top 29% of over 250 industries [8][9] - The Zacks Industry Rank suggests that the top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the potential for growth within this sector [9]
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know